Funding for this research was provided by:
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (COVID190115, COVID19F09, COVID190126)
Received: 24 June 2022
Accepted: 10 October 2022
First Online: 21 October 2022
: CWT and L-FW are co-inventors of the surrogate virus neutralization test commercialized by GenScript under the trade name cPass. Other authors declare no conflicts of interest.